東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

A Method for Identification of Pancreatic Cancer Through Methylation Signatures in Cell-Free DNA.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	A Method for Identification of Pancreatic Cancer Through Methylation Signatures in Cell-Free DNA./
作者:	Miller, Neil Andrew.
面頁冊數:	1 online resource (113 pages)
附註:	Source: Dissertations Abstracts International, Volume: 84-02, Section: B.
Contained By:	Dissertations Abstracts International84-02B.
標題:	Bioinformatics. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29325731click for full text (PQDT)
ISBN:	9798841781844

A Method for Identification of Pancreatic Cancer Through Methylation Signatures in Cell-Free DNA.
Miller, Neil Andrew.

A Method for Identification of Pancreatic Cancer Through Methylation Signatures in Cell-Free DNA. - 1 online resource (113 pages)

Source: Dissertations Abstracts International, Volume: 84-02, Section: B.

Thesis (Ph.D.)--University of Missouri - Kansas City, 2022.

Includes bibliographical references

Pancreatic cancer has high mortality rates in comparison to other cancers due to limited treatment options and challenges in detecting the disease. Early diagnosis is difficult; successful outcomes are directly tied to detection of the cancer before it can spread throughout the body. Evaluation of circulating cell-free DNA (cfDNA), specifically, detection of circulating tumor DNA (ctDNA), is being explored as an approach for non-invasive 'liquid biopsy' that can be deployed widely and cost-effectively to screen for early signs of disease. DNA methylation signatures found in cfDNA can serve as a biomarker for detection of cancer. Previous efforts to detect pancreatic cancer using cfDNA showed limited sensitivity for detection. This manuscript describes work to develop a method for early detection of pancreatic cancer in circulating cell-free DNA using publicly available data from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO). The work includes the development of methods for simulation of samples and cell-free DNA data at multiple ctDNA concentrations as well as a pilot implementation and evaluation of a machine learning model for automated classification of cfDNA samples.Chapter 1 introduces background of pancreatic cancer, cfDNA, liquid biopsy, DNA methylation and DNA methylation in cancer as well as a review of previous efforts to develop early detection applications.Chapter 2 describes the identification of DNA methylation markers that distinguish pancreatic tumor from normal pancreas and blood using publicly available data from the TCGA and GEO. In addition, the chapter outlines the development of a machine learning model to classify samples as tumor or normal based on these markers.Chapter 3 gives an overview of the challenges of genetic data simulation and the development of a novel tool, Heisenberg, for simulating DNA methylation data and cfDNA methylation data. This chapter also illustrate the use of Heisenberg to simulate normal blood samples and pancreatic cancer cfDNA samples.Chapter 4 describes the development of a neural network classification model for detection of pancreatic tumor in different concentrations of cfDNA using simulated samples. The chapter also reports the detection performance of the model using different model training strategies.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2023

Mode of access: World Wide Web

ISBN: 9798841781844Subjects--Topical Terms:

553671
Bioinformatics.
Subjects--Index Terms:

Cell-free DNAIndex Terms--Genre/Form:

542853
Electronic books.

A Method for Identification of Pancreatic Cancer Through Methylation Signatures in Cell-Free DNA.
LDR:03750nmm a2200409K 4500 001 2365695
005 20231218204640.5
006 m o d
007 cr mn ---uuuuu
008 241011s2022 xx obm 000 0 eng d
020 $a 9798841781844
035 $a (MiAaPQ)AAI29325731
035 $a AAI29325731
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Miller, Neil Andrew. $3 3706558
245 1 2 $a A Method for Identification of Pancreatic Cancer Through Methylation Signatures in Cell-Free DNA.
264 0 $c 2022
300 $a 1 online resource (113 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 84-02, Section: B.
500 $a Advisor: Wyckoff, Gerald J.
502 $a Thesis (Ph.D.)--University of Missouri - Kansas City, 2022.
504 $a Includes bibliographical references
520 $a Pancreatic cancer has high mortality rates in comparison to other cancers due to limited treatment options and challenges in detecting the disease. Early diagnosis is difficult; successful outcomes are directly tied to detection of the cancer before it can spread throughout the body. Evaluation of circulating cell-free DNA (cfDNA), specifically, detection of circulating tumor DNA (ctDNA), is being explored as an approach for non-invasive 'liquid biopsy' that can be deployed widely and cost-effectively to screen for early signs of disease. DNA methylation signatures found in cfDNA can serve as a biomarker for detection of cancer. Previous efforts to detect pancreatic cancer using cfDNA showed limited sensitivity for detection. This manuscript describes work to develop a method for early detection of pancreatic cancer in circulating cell-free DNA using publicly available data from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO). The work includes the development of methods for simulation of samples and cell-free DNA data at multiple ctDNA concentrations as well as a pilot implementation and evaluation of a machine learning model for automated classification of cfDNA samples.Chapter 1 introduces background of pancreatic cancer, cfDNA, liquid biopsy, DNA methylation and DNA methylation in cancer as well as a review of previous efforts to develop early detection applications.Chapter 2 describes the identification of DNA methylation markers that distinguish pancreatic tumor from normal pancreas and blood using publicly available data from the TCGA and GEO. In addition, the chapter outlines the development of a machine learning model to classify samples as tumor or normal based on these markers.Chapter 3 gives an overview of the challenges of genetic data simulation and the development of a novel tool, Heisenberg, for simulating DNA methylation data and cfDNA methylation data. This chapter also illustrate the use of Heisenberg to simulate normal blood samples and pancreatic cancer cfDNA samples.Chapter 4 describes the development of a neural network classification model for detection of pancreatic tumor in different concentrations of cfDNA using simulated samples. The chapter also reports the detection performance of the model using different model training strategies.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2023
538 $a Mode of access: World Wide Web
650 4 $a Bioinformatics. $3 553671
650 4 $a Computer science. $3 523869
650 4 $a Medicine. $3 641104
653 $a Cell-free DNA
653 $a Genomics
653 $a Liquid biopsy
653 $a Machine learning
653 $a Methylation
653 $a Pancreatic cancer
655 7 $a Electronic books. $2 lcsh $3 542853
690 $a 0715
690 $a 0984
690 $a 0564
710 2 $a ProQuest Information and Learning Co. $3 783688
710 2 $a University of Missouri - Kansas City. $b Bioinformatics. $3 3560845
773 0 $t Dissertations Abstracts International $g 84-02B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=29325731 $z click for full text (PQDT)